Header Logo

Connection

Yuki Kageyama to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Yuki Kageyama has written about Antibodies, Monoclonal.
Yuki Kageyama
Connection Strength
0.042
Antibodies, Monoclonal
  1. The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis. Rheumatology (Oxford). 2006 Jun; 45(6):761-4.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.